Vimarsana
Biggest News Aggregation in the World

Page 9 - Yield10 Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Yield10 Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Yield10 Bioscience Today - Breaking & Trending Today

Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference - Vimarsana News

Yield10 Bioscience to Present at the 24th Annual H.C. Wainwright Global Investment Conference

WOBURN, Mass., Sept. 08, 2022 -- Yield10 Bioscience, Inc. , an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview... | September 8, 2022

Yield10 Bioscience : Oliver Peoples, Ph.D. Recognized As "AgTech CEO of the Year" By AgTech Breakthrough - Vimarsana News

Yield10 Bioscience : Oliver Peoples, Ph.D. Recognized As "AgTech CEO of the Year" By AgTech Breakthrough

Annual Awards Program Recognizes Innovation in Agricultural & Food Technologies Around the Globe ‍ On August 25, we announced that our very own Olly... | August 25, 2022

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell - Vimarsana News

Yield10 Bioscience Chief Science Officer Dr. Kristi Snell

WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,...

Yield10 Bioscience (NASDAQ:YTEN) Lifted to Buy at Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Lifted to Buy at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The brokerage presently has a $2.75 price target on the specialty chemicals company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 9.13% from […]

Yield10 Bioscience (NASDAQ:YTEN) Cut to Hold at Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Cut to Hold at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance […]